Invention Grant
US08409619B2 Oral drug delivery system for azole, moxifloxacin and rifampicin
有权
唑类，莫西沙星和利福平口服药物输送系统
- Patent Title: Oral drug delivery system for azole, moxifloxacin and rifampicin
- Patent Title (中): 唑类，莫西沙星和利福平口服药物输送系统
-
Application No.: US12682698Application Date: 2008-10-15
-
Publication No.: US08409619B2Publication Date: 2013-04-02
- Inventor: Gopal Krishan Khuller , Jitendra Nath Verma
- Applicant: Gopal Krishan Khuller , Jitendra Nath Verma
- Applicant Address: IN Kolkata
- Assignee: Lifecare Innovations Pvt. Ltd.
- Current Assignee: Lifecare Innovations Pvt. Ltd.
- Current Assignee Address: IN Kolkata
- Agency: The Webb Law Firm
- International Application: PCT/IN2008/000675 WO 20081015
- International Announcement: WO2010/044089 WO 20100422
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K31/497
Abstract:
An oral drug delivery system for treatment of tuberculosis is described. The oral drug delivery system includes (e.g., a mixture or combination of): poly DL-lactide-co-glycolide nano particles having encapsulated an azole therein; poly DL-lactide-co-glycolide nano particles having moxifloxacin encapsulated therein; and poly DL-lactide-co-glycolide nano particles having RIF encapsulated therein.
Public/Granted literature
- US20100310662A1 Oral Drug Delivery System for Azole, Moxifloxacin and Rifampicin Public/Granted day:2010-12-09
Information query
